- Min.Order :50 Milligram
- Purity: ＞98％
- Payment Terms : T/T,,MoneyGram,Other
Keywords
1626387-80-1 AZD3759 in stock
Quick Details
- Appearance:
- Application:laboratory research
- PackAge:As your request
- ProductionCapacity:|Metric Ton|Day
- Storage:
- Transportation:By air
Superiority:
High purity
NMR、HPLC will be offered
Fast delivery
Custom synthesis is available
Details:
AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon oral administration, AZD3759 binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR. This prevents EGFR-mediated signaling, and may lead to both induction of cell death and inhibition of tumor growth in EGFR-overexpressing cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. Check for active clinical trials using this agent. (NCI Thesaurus)
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View